Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.

MLA

Costagliola, Dominique, et al. “Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.” The Journal of Infectious Diseases, vol. 221, no. 4, Feb. 2020, pp. 516–22. EBSCOhost, https://doi.org/10.1093/infdis/jiz481.

APA

Costagliola, D., Potard, V., Lang, S., de Castro, N., Cotte, L., Duval, X., Duvivier, C., Grabar, S., Mary-Krause, M., Partisani, M., Ronot-Bregigeon, S., Simon, A., Tattevin, P., Weiss, L., Zucman, D., Katlama, C., Raffi, F., & Boccara, F. (2020). Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV. The Journal of Infectious Diseases, 221(4), 516–522. https://doi.org/10.1093/infdis/jiz481

Chicago

Costagliola, Dominique, Valérie Potard, Sylvie Lang, Nathalie de Castro, Laurent Cotte, Xavier Duval, Claudine Duvivier, et al. 2020. “Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.” The Journal of Infectious Diseases 221 (4): 516–22. doi:10.1093/infdis/jiz481.